November 19, 2018
Tag: Molecular Therapeutics Research Program
![UNC Lineberger's Channing Der, PhD.](https://unclineberger.org/wp-content/uploads/sites/867/2018/11/researchers-identify-resistance-mechanism-to-possible-pancreatic-cancer-treatment-image2-600x400.jpeg)
November 16, 2018
Researchers identify resistance mechanism to possible pancreatic cancer treatment
In the journal Cancer Cell, UNC Lineberger's Channing Der, PhD, and colleagues described how pancreatic cancer may develop resistance to ERK inhibitors in pancreatic cancer.
![Shawn Hingtgen, PhD](https://unclineberger.org/wp-content/uploads/sites/867/2018/11/hingtgen-600x400.jpeg)
November 2, 2018
Hingtgen awarded Hettleman Prize
UNC Lineberger's Shawn Hingtgen, PhD, is being honored with a Phillip and Ruth Hettleman Prize for Artistic and Scholarly Achievement by Young Faculty in recognition of his research that is focused on harnessing the potential of stem cells to develop new and better methods for treating terminal cancer.
![UNC Lineberger's Shawn Hingtgen, PhD, and his colleagues published preclinical findings in PLoS ONE that demonstrate an innovative approach to treating edulloblastoma, the most common form of pediatric brain cancer.](https://unclineberger.org/wp-content/uploads/sites/867/2018/10/stem-cells-show-promise-as-drug-delivery-tool-image2.jpeg)
August 27, 2018
Stem cells show promise as drug delivery tool for childhood brain cancer
UNC Lineberger’s Shawn Hingtgen, PhD, and his collaborators showed they could shrink tumors in laboratory models of medulloblastoma, and extend life. The study, published in PLOS ONE, is a necessary step toward developing clinical trials that would see if the approach works for children.